荧光共聚焦显微镜数字活检用于前列腺癌实时诊断的前瞻性比较研究
本研究前瞻性比较荧光共聚焦显微镜(FCM)与苏木精-伊红(HE)染色对前列腺穿刺活检组织的诊断能力。54例患者的427对图像由四位国际病理学家盲法评估,FCM诊断与HE最终报告几乎完全一致(准确率95.1%,κ=0.84)。FCM可即时获取近乎HE分辨率的数字图像,无需常规处理,有望加速前列腺癌诊断流程。
要点
- FCM诊断前列腺癌与HE最终报告高度一致(准确率95.1%,κ=0.84)。
- FCM与HE对前列腺癌检测的观察者间一致性均近乎完美(HE κ=0.95,FCM κ=0.86)。
- FCM与HE对ISUP分级1与>1的区分仅达中等一致性(HE κ=0.47,FCM κ=0.49)。
核心结论
- FCM可提供即时、显微镜下且看似可靠的前列腺癌诊断,无需常规组织处理即可实时获取数字图像。
研究设计与样本
- 前瞻性比较研究,2019年3月至6月单中心连续入组54例有临床和实验室指征的患者,获取427对FCM数字图像与对应HE玻璃切片。
- 四位国际病理学家在无FCM经验、盲法条件下通过专用网络平台评估所有图像。
主要发现
- FCM诊断与HE最终报告几乎完全一致,正确诊断率95.1%,κ=0.84。
- 前列腺癌检测的观察者间一致性:HE为0.98(κ=0.95),FCM为0.95(κ=0.86)。
- ISUP分级1与>1区分的观察者间一致性:HE κ=0.47,FCM κ=0.49,均为中等。
关键数值与推荐
- 主要终点为FCM在穿刺芯中识别癌组织的能力(逐切片分析),以与HE的一致水平(K值)解读。
- 次要终点为FCM或HE对癌症检测(有 vs 无)及ISUP分级1与>1区分的观察者间一致性。
临床怎么用
- FCM可实时获取数字图像并即时共享和报告,有望改进前列腺癌诊断路径。
- FCM对前列腺癌检测可靠性高,但分级一致性中等,需谨慎用于分级决策。
局限性
- FCM与HE对癌症分级(ISUP 1 vs >1)的观察者间一致性仅为中等。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: A microscopic analysis of tissue is the gold standard for cancer detection. Hematoxylin-eosin (HE) for the reporting of prostate biopsy (PB) is conventionally based on fixation, processing, acquisition of glass slides, and analysis with an analog microscope by a local pathologist. Digitalization and real-time remote access to images could enhance the reporting process, and form the basis of artificial intelligence and machine learning. Fluorescence confocal microscopy (FCM), a novel optical technology, enables immediate digital image acquisition in an almost HE-like resolution without requiring conventional processing. OBJECTIVE: The aim of this study is to assess the diagnostic ability of FCM for prostate cancer (PCa) identification and grading from PB. DESIGN, SETTING, AND PARTICIPANTS: This is a prospective, comparative study evaluating FCM and HE for prostate tissue interpretation. PBs were performed (March to June 2019) at a single coordinating unit on consecutive patients with clinical and laboratory indications for assessment. FCM digital images (n = 427) were acquired immediately from PBs (from 54 patients) and stored; corresponding glass slides (n = 427) undergoing the conventional HE processing were digitalized and stored as well. A panel of four international pathologists with diverse background participated in the study and was asked to evaluate all images. The pathologists had no FCM expertise and were blinded to clinical data, HE interpretation, and each other's evaluation. All images, FCM and corresponding HE, were assessed for the presence or absence of cancer tissue and cancer grading, when appropriate. Reporting was gathered via a dedicated web platform. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: The primary endpoint is to evaluate the ability of FCM to identify cancer tissue in PB cores (per-slice analysis). FCM outcomes are interpreted by agreement level with HE (K value). Additionally, either FCM or HE outcomes are assessed with interobserver agreement for cancer detection (presence vs absence of cancer) and for the discrimination between International Society of Urologic Pathologists (ISUP) grade = 1 and ISUP grade > 1 (secondary endpoint). RESULTS AND LIMITATIONS: Overall, 854 images were evaluated from each pathologist. PCa detection of FCM was almost perfectly aligned with HE final reports (95.1% of correct diagnosis with FCM, κ = 0.84). Inter-rater agreement between pathologists was almost perfect for both HE and FCM for PCa detection (0.98 for HE, κ = 0.95; 0.95 for FCM, κ = 0.86); for cancer grade attribution, only a moderate agreement was reached for both HE and FCM (HE, κ = 0.47; FCM, κ = 0.49). CONCLUSIONS: FCM provides a microscopic, immediate, and seemingly reliable diagnosis for PCa. The real-time acquisition of digital images-without requiring conventional processing-offers opportunities for immediate sharing and reporting. FCM is a promising tool for improvements in cancer diagnostic pathways. PATIENT SUMMARY: Fluorescence confocal microscopy may provide an immediate, microscopic, and apparently reliable diagnosis of prostate cancer on prostate biopsy, overcoming the standard turnaround time of conventional processing and interpretation.
引用
- Rocco B, Sighinolfi MC, Sandri M, et al. Digital Biopsy with Fluorescence Confocal Microscope for Effective Real-time Diagnosis of Prostate Cancer: A Prospective, Comparative Study. Eur Urol Oncol. 2020. PMID: 32952095. doi:10.1016/j.euo.2020.08.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。